This record was last updated January 17, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the study is to find out whether non-responsiveness to therapeutic recombinant human granulocyte colony-stimulation factor (rhG-CSF) is associated with hemophagocytosis in critically ill adult patients with cytopenias.
Protocol Amendment History
6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2013-07-30; most recent amendment 2024-01-16.